PIKFYVE and acute lymphoblastic leukemia: IKAROS binding to the promoter of PIK3CD and PIKFYVE was further confirmed by quantitative chromatin immunoprecipitation (qChIP) in human T-ALL cell lines MOLT4 and CEM and primary T-ALL cells labeled T-ALL#1 (Figure 2C,D).